10:02:59 EDT Wed 16 Oct 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for Sept. 16, 2019

2019-09-16 20:59 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index inched 0.14 point to 544.89 Monday. United States-based Cresco Labs Inc. (CL) dropped 91 cents to $9.59 on 1.95 million shares after a busy day, which included the announcement of a $282.5-million (U.S.) asset acquisition of Tryke Companies. Cresco Labs will receive six dispensaries spread throughout Arizona and Nevada, as well as cultivation space in each of those states. The company will obtain 160,200 square feet of cultivation and processing area in Nevada and 27,000 square feet in Arizona. Cresco Labs will also receive a cultivation licence for Utah, which will be the 12th state in which Cresco has operations.

Of the $282.5-million (U.S.) purchase price, Cresco Labs will pay $252.5-million (U.S.) for Tryke's operating assets plus $30-million (U.S.) for Tryke's real estate assets. The U.S. cannabis producer will pay for the acquisition through a $227.5-million (U.S.) share issuance and it will pay the remaining $55-million (U.S.) in cash. Cresco Labs says it expects the deal to close in the first half of 2020.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2019 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.